Show simple item record

Authordc.contributor.authorZumarán, Consuelo 
Authordc.contributor.authorParra, Marcelo 
Authordc.contributor.authorOlate, Sergio 
Authordc.contributor.authorFernández Godoy, Eduardo 
Authordc.contributor.authorMuñoz, Francisco 
Authordc.contributor.authorHaidar, Ziyad 
Admission datedc.date.accessioned2018-12-20T15:25:09Z
Available datedc.date.available2018-12-20T15:25:09Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationMaterials, Volumen 11, Issue 8, 2018.
Identifierdc.identifier.issn19961944
Identifierdc.identifier.other10.3390/ma11081293
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/159168
Abstractdc.description.abstractPlatelet-Rich fibrin (PRF) is a three-dimensional (3-D) autogenous biomaterial obtained via simple and rapid centrifugation from the patient’s whole blood samples, without including anti-coagulants, bovine thrombin, additives, or any gelifying agents. At the moment, it is safe to say that in oral and maxillofacial surgery, PRFs (particularly, the pure platelet-rich fibrin or P-PRF and leukocyte and platelet-rich fibrin or L-PRF sub-families) are receiving the most attention, essentially because of their simplicity, cost-effectiveness, and user-friendliness/malleability; they are a fairly new “revolutionary” step in second-generation therapies based on platelet concentration, indeed. Yet, the clinical effectiveness of such surgical adjuvants or regenerative platelet concentrate-based preparations continues to be highly debatable, primarily as a result of preparation protocol variability, limited evidence-based clinical literature, and/or poor understanding of bio-components and clinico-mechanical properties. To provide a practical update on the application of PRFs during oral surgery procedures, this critical review focuses on evidence obtained from human randomized and controlled clinical trials only. The aim is to serve the reader with current information on the clinical potential, limitations, challenges, and prospects of PRFs. Accordingly, reports often associate autologous PRFs with early bone formation and maturation; accelerated soft-tissue healing; and reduced post-surgical edema, pain, and discomfort. An advanced and original tool in regenerative dentistry, PRFs present a strong alternative and presumably cost-effective biomaterial for oro-maxillo-facial tissue (soft and hard) repair and regeneration. Yet, preparation protocols continue to be a source of confusion, thereby requiring revision and standardization. Moreover, to increase the validity, comprehension, and therapeutic potential of the reported findings or observations, a decent analysis of the mechanico-rheological properties, bio-components, and their bioactive function is eagerly needed and awaited; afterwards, the field can progress toward a brand-new era of “super” oro-dental biomaterials and bioscaffolds for use in oral and maxillofacial tissue repair and regeneration, and beyond.
Lenguagedc.language.isoen
Publisherdc.publisherMDPI AG
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceMaterials
Keywordsdc.subjectDentistry
Keywordsdc.subjectFibrin
Keywordsdc.subjectGrafts
Keywordsdc.subjectGrowth factors
Keywordsdc.subjectLeukocyte
Keywordsdc.subjectOral surgery
Keywordsdc.subjectOsteogenesis
Keywordsdc.subjectPeriodontology
Keywordsdc.subjectPlatelet
Keywordsdc.subjectRegeneration
Keywordsdc.subjectTissue engineering
Títulodc.titleThe 3 R's for platelet-rich fibrin: A "super" tri-dimensional biomaterial for contemporary naturally-guided oro-maxillo-facial soft and hard tissue repair, reconstruction and regeneration
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorjmm
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile